SEC Form 4/A · accession 0001209191-18-009449
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Lewis T Williams
Officer — Executive Chairman · Director
Period of report
Sep 1, 2016
Accepted (ET)
Feb 13, 2018 · 11:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 1, 2016 | G | 0 | $0.00 | D | 428,827 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed to reflect that a gift of 22,416 shares of common stock was inadvertently disclosed in the original Form 4 filed with the Securities and Exchange Commission (the "SEC") on February 9, 2017. This gift was already reported in a Form 4 filed with the SEC on September 1, 2016 and as such, the original Form 4 filed on February 9, 2017 should not have included a line item for this gift. This amendment cannot be filed without a completed line item, and as such, this amendment shows that no shares were gifted.